The decreased CPSI expression in CHD-PAH patients may reveal a mechanism that is responsible for decreased endogenous NO in the development of PAH and the decrease of CFHR2 protein may demonstrate the deficiency of the immune system and coagulation mechanism in these patients. This evidence concerns the gene CFHR2 and pulmonary arterial hypertension.